DZ Bank
IRWD icon

DZ Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

DZ Bank’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-347,016
Closed -$3.97M – 1068
2023
Q4 		$3.97M Sell
347,016
-211,324
-38% -$2.09M ﹤0.01% 487
2023
Q3 		$5.38M Sell
558,340
-11,281
-2% -$111K 0.01% 440
2023
Q2 		$6.06M Buy
569,621
+15,845
+3% +$170K 0.01% 433
2023
Q1 		$5.83M Buy
553,776
+360,341
+186% +$4.04M 0.01% 437
2022
Q4 		$2.4M Sell
193,435
-35,749
-16% -$406K ﹤0.01% 566
2022
Q3 		$2.37M Buy
229,184
+3,878
+2% +$44K ﹤0.01% 545
2022
Q2 		$2.6M Buy
225,306
+142,939
+174% +$1.68M ﹤0.01% 564
2022
Q1 		$1.04M Buy
+82,367
New +$944K ﹤0.01% 721
2018
Q2 		– Sell
-392,818
Closed -$5.08M – 962
2018
Q1 		$5.08M Buy
+392,818
New +$4.9M 0.02% 398

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

DZ Bank's IRWD Position: Q1 2024 in Review

DZ Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 347,016 shares — an estimated $3.97M sold.

DZ Bank first reported a position in IRWD in Q1 2018 and held it in 9 quarters. The position peaked at $6.06M in Q2 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • DZ Bank reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • DZ Bank sold 347,016 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $3.97M.
  • DZ Bank first reported a position in Ironwood Pharmaceuticals in Q1 2018 and held it in 9 quarters.
  • DZ Bank's Ironwood Pharmaceuticals position peaked at $6.06M in Q2 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on DZ Bank's 13F filing for Q1 2024, filed 15 May 2024.